Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Research and development expenses	$ 6,030	$ 1,961
General and administrative expenses	4,324	602
Change in fair value of tranche liability	365	0
Change in fair value of derivative liability	1,229	0
Interest expense	1,443	78
Loss on issuance of convertible promissory notes	(186)	(793)
Related Party
Research and development expenses	13	46
General and administrative expenses	151	49
Change in fair value of tranche liability	331	0
Change in fair value of derivative liability	1,165	0
Interest expense	1,384	78
Loss on issuance of convertible promissory notes	$ 169	$ 793